Cart
sales@molnova.com
nor-NOHA acetate
CAS No. 1140844-63-8
nor-NOHA acetate( Nω-Hydroxy-nor-L-arginine acetate )
Catalog No. M26337 CAS No. 1140844-63-8
nor-NOHA acetate is a reversible inhibitor of arginase, with anti-leukemic activity, effective in endothelial dysfunction, immunosuppression, and metabolism.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 299 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product Namenor-NOHA acetate
-
NoteResearch use only, not for human use.
-
Brief Descriptionnor-NOHA acetate is a reversible inhibitor of arginase, with anti-leukemic activity, effective in endothelial dysfunction, immunosuppression, and metabolism.
-
Descriptionnor-NOHA acetate is a reversible inhibitor of arginase, with anti-leukemic activity, effective in endothelial dysfunction, immunosuppression, and metabolism.
-
In Vitro——
-
In Vivo——
-
SynonymsNω-Hydroxy-nor-L-arginine acetate
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorGram-positive Bacterial| HSV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1140844-63-8
-
Formula Weight296.28
-
Molecular FormulaC9H20N4O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 200 mg/mL (675.04 mM)
-
SMILESCC(O)=O.CC(O)=O.N[C@@H](CCNC(=N)NO)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chan WY, et al. In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa.Vet Dermatol. 2019 Apr;30(2):133-e38.
molnova catalog
related products
-
Nebularine
Nebularine (9-(beta-D-Ribofuranosyl)-9H-purine) is a purine nucleoside analog with a broad spectrum of antitumor activity, targeting inert lymphoid malignancies and inducing apoptosis.
-
TD52
TD52 is an orally active inhibitor of cancerous inhibitor of PP2A (CIP2A). TD52 is an Erlotinib derivative and indirectly reduced CIP2A by disturbing Elk1 binding to the CIP2A promoter.
-
EAD1 TFA(1644388-26-...
EAD1 HCL is a potent autophagy inhibitor with antiproliferative activity in lung and pancreatic cancer cells. EAD1 HCL also induces apoptosis
